Drug Shortage Report for JAMP RABEPRAZOLE
| Report ID | 180283 |
| Drug Identification Number | 02415291 |
| Brand name | JAMP RABEPRAZOLE |
| Common or Proper name | Rabeprazole Sodium Delayed Release Tablets |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | DORMANT |
| Active Ingredient(s) | RABEPRAZOLE SODIUM |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2022-12-09 |
| Estimated end date | 2023-02-10 |
| Actual end date | 2023-01-27 |
| Shortage status | Resolved |
| Updated date | 2023-01-31 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-01-31 | French | Compare |
| v5 | 2023-01-31 | English | Compare |
| v4 | 2023-01-10 | French | Compare |
| v3 | 2023-01-10 | English | Compare |
| v2 | 2023-01-09 | French | Compare |
| v1 | 2023-01-09 | English | Compare |
Showing 1 to 6 of 6